Follow the 乐心医疗 share price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 乐心医疗 has logged 5 public disclosures. Market capitalisation: €2.9bn. The latest transaction was reported on 5 March 2025 (Sale). Among the most active insiders: 潘伟潮. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
乐心医疗 es una empresa centrada en el sector de la salud y farmacéutico, que ofrece soluciones innovadoras para el bienestar del paciente. Cotiza en el mercado XSHE.